Pemrydi Rtu
Payments companies reported to CMS as associated with Pemrydi Rtu. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Pemrydi Rtu, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Pemrydi Rtu
These are the largest totals companies reported as associated with Pemrydi Rtu. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Eric Schaefer | Fayetteville, AR | Hematology & Oncology | $94.68 |
| Gary Kay | Elk Grove Village, IL | Hematology & Oncology | $88.68 |
| Harsha Vyas | Dublin, GA | Hematology & Oncology | $88.68 |
| Mohamed Sayed | Gainesville, FL | Ophthalmology | $29.82 |
| Julian Parent | Bakersfield, CA | Physician Assistant | $28.17 |
| Croix Fossum | San Diego, CA | Radiation Oncology | $28.17 |
| Kelly Dewitt | La Mesa, CA | Radiation Oncology | $28.17 |
| Reema Batra | La Mesa, CA | Hematology & Oncology | $28.17 |
| Judah Friedman | Palm Beach Gardens, FL | Medical Oncology | $27.42 |
| Carl Gray | Ogden, UT | Hematology & Oncology | $26.92 |
Prescribed Pemrydi Rtu?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.